Literature DB >> 6930312

Changing priorities in Hodgkin's disease.

C J Williams.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6930312      PMCID： PMC1601588          DOI： 10.1136/bmj.280.6227.1310

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  18 in total

1.  The management of Hodgkin's disease.

Authors:  H S Kaplan; S A Rosenberg
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Hematologic neoplasia in patients treated for Hodgkin's disease.

Authors:  C N Coleman; C J Williams; A Flint; E J Glatstein; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

Review 3.  The chemotherapy of Hodgkin's disease: past experiences and future directions.

Authors:  V T DeVita; B J Lewis; M Rozencweig; F M Muggia
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

4.  Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.

Authors:  M R Moore; J M Bull; S E Jones; S A Rosenberg; H S Kaplan
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

5.  Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease.

Authors:  M E Kadin; E Glatstein; R F Dorfman
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

6.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

8.  Letter: second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos
Journal:  Lancet       Date:  1975-06-07       Impact factor: 79.321

9.  Lymphangiography in Hodgkin's disease: indications and contraindications.

Authors:  B J Lee
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.

Authors:  R K Desser; H M Golomb; J E Ultmann; D J Ferguson; E M Moran; M L Griem; J Vardiman; B Miller; N Oetzel; D Sweet; E P Lester; J J Kinzie; R Blough
Journal:  Blood       Date:  1977-06       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.